ETFs
I
IDXG
Interpace Biosciences Inc
1.700
+0.070+4.29%Closed15:32 06/24 EDT
OPEN/PREV CLOSE1.680/1.630
TODAY RANGE1.680-1.700
VOL3.21K
MARKET CAP47.09M
52 WEEK RANGE0.700-2.380
AVG VOL (3M)3.40K
% TURNOVER0.01%
TURNOVER5.45K
P/E (TTM)2.322
% RANGE1.23%
EPS(TTM)0.732
P/E(FORWARD)0.369
P/B2.040
BVPS0.833
DIVIDEND--
P/S0.194
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP6.98M
SHARES OUTSTANDING27.70M
NEXT EARNINGS08/05-08/10
FREE FLOAT4.11M
LOT SIZE100
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·05/12 20:47
Interpace Biosciences GAAP EPS of $0.03, revenue of $9.03M
Seeking Alpha·03/30 20:05
Interpace Biosciences GAAP EPS of $0.82, revenue of $9.22M
TipRanks·01/20 14:40
Interpace Diagnostics Guides 2026 Growth After Balance Sheet Cleanup
TipRanks·01/20 14:12
Interpace Biosciences sees FY25 revenue $38M-$39M
TipRanks·01/20 14:11
Interpace Biosciences sees FY26 revenue $40M
TipRanks·01/20 14:11
Interpace Biosciences announces preferred stock conversion
TipRanks·01/20 14:10
Interpace Biosciences to seek uplisting to Nasdaq Stock Market
TipRanks·12/03/2025 21:34
Interpace Biosciences Repays Loan Early for Growth
Seeking Alpha·11/13/2025 05:54
Interpace Biosciences GAAP EPS of $0.04, revenue of $8.76M
TipRanks·11/13/2025 03:59
Interpace Biosciences Reports Q3 2025 Earnings
TipRanks·09/15/2025 13:20
Interpace Biosciences presents two posters at ATA meeting
TipRanks·08/08/2025 06:09
Interpace Biosciences Reports Q2 2025 Earnings
Seeking Alpha·08/07/2025 21:39
Interpace Biosciences GAAP EPS of -$0.14, revenue of $9.2M
Same Industry